Li Hua Zheng
Gründer bei AnHeart Therapeutics (Hangzhou) Co., Ltd.
Aktive Positionen von Li Hua Zheng
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
 AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Direktor/Vorstandsmitglied | 27.11.2018 | - |
| Gründer | 27.11.2018 | - | |
| Corporate Officer/Principal | 27.11.2018 | - | |
| Anbio, Inc. | Direktor/Vorstandsmitglied | 01.12.2017 | - |
| Gründer | 01.12.2017 | - | |
| Zheng & Karg LLP | Corporate Officer/Principal | 01.01.2018 | - |
Karriereverlauf von Li Hua Zheng
Ehemalige bekannte Positionen von Li Hua Zheng
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Liu, Zheng, Chen & Hoffman LLP | Corporate Officer/Principal | 01.10.2015 | 01.12.2017 |
| UCOMMUNE INTERNATIONAL LTD | Direktor/Vorstandsmitglied | 01.12.2018 | - |
| Independent Dir/Board Member | 01.12.2018 | - |
Ausbildung von Li Hua Zheng
| Baylor College of Medicine | Doctorate Degree |
| Fudan University | Graduate Degree |
| Fordham University School of Law | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| China | 3 |
Operativ
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Graduate Degree | 2 |
Sektoral
| Consumer Services | 4 |
| Commercial Services | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Commercial Services |
Orisun Acquisition Corp.
 Orisun Acquisition Corp. Financial ConglomeratesFinance Orisun Acquisition Corp. is a blank check company, which engages in the provision of merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, with one or more target businesses. The company was founded on October 22, 2018 and is headquartered in New York, NY. | Finance |
| Anbio, Inc. | |
| Zheng & Karg LLP | |
| Liu, Zheng, Chen & Hoffman LLP |
- Börse
- Insiders
- Li Hua Zheng
- Erfahrung
